REFERENCES
- Cohen M., Meek M. E., Klaunig J. E., Patton D. E., Fenner-Crisp P. A. The human relevance of information on carcinogenic modes of action: an overview. Crit. Rev. Toxicol. 2003; 33: 581–589
- Committee on Carcinogenicity. Guidance on a Strategy for the Risk Assessment of Chemical Carcinogens. Department of Health, London, United Kingdom 2004
- Cortopassi G. A., Wang E. There is substantial agreement among interspecies estimates of DNA repair activity. Mech. Ageing Dev. 1996; 91: 211–218
- Hanawalt P. C. Revisiting the rodent repairadox. Environ. Mol. Mutagen. 2001; 38: 89–96
- Holsapple M. P., Pitot H. C., Cohen S. M., Boobis A. R., Klaunig J. E., Pastoor T., Dellarco V. L., Dragan Y. P. Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol. Sci. 2006; 89: 51–56
- IPCS. Scoping meeting to address the human relevance of animal modes of action in assessing cancer risk, Carshalton, United Kingdom, 8–10 November 2000. World Health Organization, International Programme on Chemical Safety, Geneva 2000, http://www.who.int/ipcs/methods/harmonization/areas/cancer/en/index.html
- IPCS. Report of the first meeting of the Cancer Working Group, Arlington, Virginia, USA, 3–5 March 2004. World Health Organization, International Programme on Chemical Safety, Geneva 2004, http://www.who.int/ipcs/methods/harmonization/areas/cancer/en/index.html
- IPCS. Record of the Cancer Framework Workshop, Bradford, United Kingdom, 21–23 April 2005. World Health Organization, International Programme on Chemical Safety, Geneva 2005, http://www.who.int/ipcs/methods/harmonization/areas/cancer/en/index.html
- National Research Council. Risk Assessment in the Federal Government. Managing the Process. National Academy Press, Washington, DC 1983
- Meek M. E., Bucher J. R., Cohen S. M., Dellarco V., Hill R. N., Lehman-McKeeman L. D., Longfellow D. G., Pastoor T., Seed J., Patton D. E. A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol. 2003; 33: 591–653
- Preston J. R., Williams G. M. DNA-reactive carcinogens: Mode of action and human cancer hazard. Crit. Rev. Toxicol. 2005; 35: 673–683
- Slikker W., Jr., Andersen M. E., Bogdanffy M. S., Bus J. S., Cohen S. D., Conolly R. B., David R. M., Doerrer N. G., Dorman D. C., Gaylor D. W., Hattis D., Rogers J. M., Setzer R. W., Swenberg J. A., Wallace K. Dose-dependent transitions in mechanisms of toxicity: Case studies. Toxicol. Appl. Pharmacol. 2004; 20: 226–294
- Sonich-Mullin C., Fielder R., Wiltse J., Baetcke K., Dempsey J., Fenner-Crisp P., Grant D., Hartley M., Knaap A., Kroese D., Mangelsdorf I., Meek E., Rice J., Younes M. IPCS Conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul. Toxicol. Pharmacol. 2001; 34: 146–152
- U.S. Environmental Protection Agency. Guidelines for Carcinogen Risk Assessment (Review Draft). Risk Assessment Forum, Washington, DC 1999, NCEA-F-0644
- U.S. Environmental Protection Agency. Guidelines for Carcinogen Risk Assessment. Risk Assessment Forum, Washington, DC 2005, EPA/639/P-03/001F